Skip to content

Psychedelic-assisted therapy: all studies

Page 243 of 294: studies 2,421 to 2,430 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives

Frontiers in Pharmacology July 22, 2022 Leor Roseman, Katrin H. Preller, Evgenia Fotiou et al. 15 citations

The heralded psychedelic renaissance is currently at a new level where psychedelics are being accepted by the scientific community and the public. Medicalization and the ongoing introduction of market forces are imposing a trend in which psychedelic treatments are reduced to focus into strictly pharmacological and psychological effects on the self, rather than interactions with broader social...

Psychedelics, Atheism, and Naturalism Myth and Reality

Journal of Consciousness Studies July 14, 2022 Chris Letheby 2 citations

An emerging body of research suggests that psychedelic experiences can change users' religious or metaphysical beliefs. Here I explore issues concerning psychedelic-induced belief change via a critique of some recent arguments by Wayne Glausser. Two scientific studies seem to show that psychedelic experiences can convert atheists to belief in God, but Glausser holds that academic and popular...

DOI: 10.53765/20512201.29.7.069 (opens in new tab) Metaphysics Naturalism Atheism Epistemology +3

Обґрунтування можливості використання психофармакотерапевтичних методів для подолання негативного впливу російської війни на психічне здоров’я населення

Insight the psychological dimensions of society July 12, 2022 Олег Вікторович Орлов 1 citation

Метою дослідження є характеристика методу РАТ (Psychedeilc Assisted Therapy) та окреслення перспектив його впровадження в Україні. Методологія та методи. Використано методи теоретичного аналізування наукової літератури. Результати. З’ясовано, що за попередніми оцінками, щонайменше 23.5 млн. українських громадян ризикують зустрітися з погіршенням психічного здоров’я: до 20.0% з них – середнього...

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review

Frontiers in Psychiatry July 12, 2022 Kwonmok Ko, Gemma Knight, James Rucker et al. 296 citations

The mystical experience is a potential psychological mechanism to influence outcome in psychedelic therapy. It includes features such as oceanic boundlessness, ego dissolution, and universal interconnectedness, which have been closely linked to both symptom reduction and improved quality of life. In this review, 12 studies of psychedelic therapy utilizing psilocybin, ayahuasca, or ketamine were...

DOI: 10.3389/fpsyt.2022.917199 (opens in new tab) Anxiety Clinical psychology Psychotherapist Distress

From personal to transpersonal? An evolutionary stance and ‘self’ as the centre of narrative gravity

The Innovation July 11, 2022 Timothy P. Jackson

For an ‘evolutionary thinker’, storytelling may be considered a shared derived trait (synapomorphy) of the human lineage. Once we began to tell stories, they became a key trait shaping our subsequent evolution. Furthermore, whether the ‘centre of narrative gravity’ is cosmological (as in creation myths) or focused on an individual character, the form of narrative is itself evolutionary,...

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees

Frontiers in Psychiatry July 7, 2022 Maggie Kiraga, Kim P. C. Kuypers, Malin V. Uthaug et al. 24 citations

Anxiety disorders are the most common type of psychiatric disorders among Western countries. Evidence-based treatment modalities including pharmacological and cognitive-behavioral therapy result in deficient treatment responses. Historical and recent research suggests psychedelic drugs may be efficacious in alleviating anxiety-related symptoms among healthy and clinical populations. The main...

Psychedelics in the treatment of unipolar and bipolar depression

International Journal of Bipolar Disorders July 5, 2022 Oliver G. Bosch, Simon Halm, Erich Seifritz 35 citations

Abstract This is a narrative review about the role of classic and two atypical psychedelics in the treatment of unipolar and bipolar depression. Since the 1990s, psychedelics experience a renaissance in biomedical research. The so-called classic psychedelics include lysergic acid diethylamide (LSD), psilocybin, mescaline and ayahuasca. Characteristic effects like alterations in sensory...

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice.

Journal of Psychopharmacology July 2022 Lauri Elsilä, Juliana Harkki, Emma Enberg et al.

Psychedelics, like lysergic acid diethylamide (LSD), are again being studied as potential therapies for many neuropsychiatric disorders, including addictions. At the same time, the acute effects of psychedelics on rewarding behaviours have been scarcely studied. The current study aimed to clarify if LSD decreases binge-like ethanol drinking in mice, and whether the observed acute effects on...

Narrative therapy in psychedelic harm reduction: Supporting safety, agency and meaning-making

International Journal of Narrative Therapy and Community Work July 1, 2022 Blake Johns

Narrative therapy has been absent from the burgeoning body of structuralist literature on the psychedelic renaissance. This paper argues that structuralist approaches limit the application of principles of client empowerment. It demonstrates applications of politicised narrative practices to supporting client safety, agency and meaning-making. Thin pathologising and/or structuralist...

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

Frontiers in Pharmacology June 28, 2022 Nataliya S. Vorobyeva, Alena A. Kozlova 16 citations

Classical psychedelics represent a family of psychoactive substances with structural similarities to serotonin and affinity for serotonin receptors. A growing number of studies have found that psychedelics can be effective in treating various psychiatric conditions, including post-traumatic stress disorder, major depressive disorder, anxiety, and substance use disorders. Mental health disorders...